LaennecAI
Laennec AI is transforming smartphones into AI-driven digital stethoscopes to detect, prevent, and manage asthma exacerbations at home. Their solution empowers users to manage respiratory conditions proactively, reducing emergency hospital visits. The company offers virtual consultations, remote monitoring, and guided self-care, ensuring tailored solutions for specific health conditions. With advanced AI capabilities, including Convolutional Neural Networks and Recurrent Neural Networks, Laennec AI enhances patient care while easing the workload for healthcare providers and lowering costs for the NHS.
LaennecAI
Laennec AI is transforming smartphones into AI-driven digital stethoscopes to detect, prevent, and manage asthma exacerbations at home. Their solution empowers users to manage respiratory conditions proactively, reducing emergency hospital visits. The company offers virtual consultations, remote monitoring, and guided self-care, ensuring tailored solutions for specific health conditions. With advanced AI capabilities, including Convolutional Neural Networks and Recurrent Neural Networks, Laennec AI enhances patient care while easing the workload for healthcare providers and lowering costs for the NHS.
TL;DR
Product: Smartphone + adaptor functioning as an AI-enabled digital stethoscope for home lung checks (asthma, COPD)
Founders: Jase John (MBBS, MPH) and Arathy Varghese (PhD)
HQ / Locations: Cardiff, UK (also lists London and Birmingham) and Kochi, India
Funding: Pre-Seed announced Nov 15, 2024 — led by SFC Capital and OVC Ventures; total reported funding $470,000
Team size (reported): About 12 employees
Company Overview
Problem Domain
Remote monitoring and early detection/management of chronic respiratory conditions (e.g., asthma, COPD) via auscultation sound analysis
Founded
2022
Industry
Clinical AI / MedTech
Tech Stack
Funding Track Record
Announced Nov 15, 2024; closed Oct 22, 2024. Databases also list grant/support entries referencing Innovate UK, the UK National Institute for Health Research, and the Welsh Government.
Investor Signal
“Pre-seed led by SFC Capital and OVC Ventures; additional non-dilutive/grant support referenced from Innovate UK, the UK National Institute for Health Research (NIHR), and the Welsh Government.”